🕵️ Dermata Therapeutics, Inc. ($DRMA)
SEC insider & ownership activity, last 12 months · CIK 1853816 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. Gerald T. Proehl added 13.3% → 17.3%. No red-flag 8-Ks in the window.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 1 seller, $13 (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kathleen D. Scott | 0 | – | 1 | $13 | Jun 16, 2026 |
| Bedoya-Toro Munera Maria E. | 1 | value withheld pending verification | 0 | – | Feb 17, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Gerald T. Proehl | 17.3% | 13D | Feb 19, 2026 | filing ↗ | |
| Kyri K. Van Hoose | 9.0% | 13D | May 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Aug 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 16, 2026 | filing ↗ |
| Other events (8.01) | Aug 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 16, 2026 | filing ↗ |
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Other events (8.01) | Aug 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 23, 2026 | filing ↗ |
| Auditor change (4.01) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Other events (8.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 23, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Agreement terminated (1.02) | Nov 17, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Other events (8.01) | Nov 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 7, 2025 | filing ↗ |